연구동향 분석

Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation

박재범 이수형 오창권 김명수 김성주 하종원 2017년

논문상세정보
인용/피인용

' Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation' 의 참고문헌

  • Why hasn’t eliminating acute rejection improved graft survival?
    Tantravahi J Annu Rev Med 58 369-385 [2007]
  • The Banff 97 working classification of renal allograft pathology
    Racusen LC Kidney Int 55 713-723 [1999]
  • Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis
    Salvadori M Transplant Proc 42 1325-1328 [2010]
  • Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
    오창권 Yonsei Medical Journal 55 5 1341-1347 [2014]
  • Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients
    Cibrik D Clin Transplant 21 192-201 [2007]
  • Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab
    Budde K Clin Nephrol 67 164-175 [2007]
  • Reduced exposure to calcineurin inhibitors in renal transplantation
    Ekberg H N Engl J Med 357 2562-2575 [2007]
  • Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression
    Hernández D Transplantation 84 706-714 [2007]
  • Mycophenolate mofetil:safety and efficacy in the prophylaxis of acute kidney transplantation rejection
    Dalal P Ther Clin Risk Manag 5 139-149 [2009]
  • Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?
    Meier-Kriesche HU Am J Transplant 4 1289-1295 [2004]
  • Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation
    Langone A Clin Transplant 28 961-967 [2014]
  • Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
    Meier-Kriesche HU Am J Transplant 4 378-383 [2004]
  • Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to entericcoated mycophenolate sodium in renal transplant patients
    Bolin P Transplantation 84 1443-1451 [2007]
  • Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium
    Ortega F Transplantation 92 426-432 [2011]
  • Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients
    Sollinger H Transplant Proc 36 2 Suppl 517S-520S [2004]
  • Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients
    Chadban S Nephrology (Carlton) 18 63-70 [2013]
  • Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing
    Cooper M Transplant Rev (Orlando) 26 233-240 [2012]
  • Drug-induced injury in the gastrointestinal tract
    Panarelli NC Semin Diagn Pathol 31 165-175 [2014]
  • Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study
    Ekberg H Am J Transplant 7 560-570 [2007]
  • Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes
    Budde K Transplantation 83 417-424 [2007]
  • Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology
    Nankivell BJ Transplantation 78 557-565 [2004]
  • A single-centre, openlabel, prospective study of an initially short-term intensified dosing regimen of enteric-coated mycophenolate sodium with reduced cyclosporine A exposure in Chinese live-donor kidney transplant recipients
    Cai L Int J Clin Pract Suppl 181 23-30 [2014]
  • A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year
    Arns W Clin Nephrol 79 421-431 [2013]
  • A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation. Modification of Diet in Renal Disease Study Group
    Levey AS Ann Intern Med 130 461-470 [1999]
  • A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits
    Etienne I Nephrol Dial Transplant 25 3096-3106 [2010]